ArticleFrontiers in public health2026
Nursing staff experiences of participating in digital therapeutic product development: a qualitative study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Digital therapeutics (DTx) have emerged as practical tools for optimizing disease management. Due to their clinical expertise, nurses are increasingly involved in the research and development (R&D) of these products. However, while the existing literature has primarily focused on the clinical efficacy of DTx, the lived experiences and specific challenges faced by nursing staff during the development process remain largely unexplored. Methods: This qualitative study used purposive sampling to recruit 10 nursing staff members who participated in the full R&D lifecycle of DTx products. Data were collected through individual in-depth interviews and analyzed using conventional content analysis. Results: The qualitative analysis identified three major themes: (1) difficulties and challenges; (2) coping and professional transformations; and (3) needs and development. The first theme comprised subthemes including the existence of knowledge barriers, financial constraints, and challenges in team formation. The second theme included the lowering of standards, self-improvement, and seeking external assistance. The third theme addressed the cultivation of cross-specialty talent, the provision of policy support, and a focus on economic sustainability. Conclusion: Nurses' participation in DTx product development faces multiple challenges, highlighting the need to strengthen the cultivation of cross-specialty talent and enhance policy guidance. Future efforts should focus on integrating digital technologies with healthcare to promote the high-quality development of digital health applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.